CYTK
CYTK
US23282W6057
Cytokinetics, Incorporated
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
8.75B EUR
11.82B EUR
8.19B EUR
7.81B EUR
Enterprise Value
8.88B EUR
12.84B EUR
9.35B EUR
8.97B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-14.15x
--
--
--
Price to Sales
129.24x
174.69x
77.39x
90.35x
Price to Book
--
--
--
--
EV/Revenue
131.22x
189.69x
88.34x
103.79x
EV/EBITDA
-12.77x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-4.54%
-4.91%
-6.7%
-5.09%
ende